Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
General Information
Revision date
2013-12-18
Product name
BARACLUDE (entecavir) Tablets, 0.5 mg and 1.0 mg
Product Synonyms
Entecavir Tablets, 0.5 mg, 1.0 mg
1.2.1 Relevant identified uses
This material is a finished drug product for patient use. It is used for treatment of hepatitis B virus infection
Emergency telephone
Australia (Sydney) +(61)-290372994
Icons in SDS
Company Information
company name
Bristol-Myers Squibb Australia Pty Ltd
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
UN Globally Harmonized System (GHS)
2.1 Classification of the substance or mixture
Mild Eye Irritation - Category 2B Carcinogenicity - Category 2 Toxic To Reproduction - Male Reproductive Toxicity - Category 2 Toxic To Reproduction - Female Reproductive Toxicity - Category 2 Toxic To Reproduction - Developmental Toxicity - Category 2 Specific Target Organ Systemic Toxicity (Single Exposure) - Category 3 Specific Target Organ Systemic Toxicity (Repeated Exposure) - Category 1
Signal word
Danger
Hazard statements
Causes eye irritation. Suspected of causing cancer. May cause respiratory irritation Suspected of damaging fertility or the unborn child. (female reproductive toxicity, male reproductive toxicity, Developmental Toxicity) . Causes damage to organs (liver, spleen, thymus, prostate, muscle, bone marrow, testes, lymph nodes, gastrointestinal tract, kidney, heart, lungs, pancreas, blood) through prolonged or repeated exposure.
Precautionary statements
Avoid breathing dust. Use only outdoors or in a well-ventilated area. Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Use personal protective equipment as required. Do not eat, drink or smoke when using this product. Wash thoroughly after handling.